Gara Jalqabaatti › Leukemiyaa Miyeelomonosaayitiki Dargaggoo
Qorannoo klinikaalii Leukemiyaa Miyeelomonosaayitiki Dargaggoo Ameerikaa Keessatti hirmaatuu
Qorannoo 9 Leukemiyaa Miyeelomonosaayitiki Dargaggoo f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Minneapolis, MNQorannoo 4
- Philadelphia, PAQorannoo 4
- Boston, MAQorannoo 3
- Chicago, ILQorannoo 3
- Atlanta, GAQorannoo 3
- Memphis, TNQorannoo 3
- New York City, NYQorannoo 3
- Indianapolis, INQorannoo 3
- Washington, DCQorannoo 3
- Cincinnati, OHQorannoo 3
- Ann Arbor, MIQorannoo 3
- San Francisco, CAQorannoo 3
- Seattle, WAQorannoo 3
Naannoon
- CaliforniaQorannoo 3
- ColoradoQorannoo 3
- Distaarikii KoloombiyaaQorannoo 3
- FloridaQorannoo 3
- GeorgiaQorannoo 3
- IllinoisQorannoo 3
- IndianaQorannoo 3
- MassachusettsQorannoo 3
- MichiganQorannoo 3
- MinnesotaQorannoo 4
- MissouriQorannoo 3
- New YorkQorannoo 3
- OhioQorannoo 3
- PennsylvaniaQorannoo 4
- TennesseeQorannoo 3
- TexasQorannoo 3
- WashingtonQorannoo 3
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
Namoota walitti qabaa jiraSadarkaa 1/2
1 Month – 21 Years · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT05849662A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 1 hanga 18 · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT06247787The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Namoota walitti qabaa jiraSadarkaa 1/2
Hanga umuriin 22 · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT04726241CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT
Namoota walitti qabaa jira
Hanga umuriin 25 · Saalaa hunda · Haaromfame 08-Ado-2026 · NCT03810196Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
Namoota walitti qabaa jiraSadarkaa 2
Hanga umuriin 60 · Saalaa hunda · Haaromfame 25-Wax-2026 · NCT03314974A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 17-Wax-2026 · NCT04024761Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases
Namoota walitti qabaa jiraSadarkaa 2
6 Months – 39 Years · Saalaa hunda · Haaromfame 04-Wax-2026 · NCT05800210HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Namoota walitti qabaa jiraSadarkaa 1
Hanga umuriin 80 · Saalaa hunda · Haaromfame 18-Cam-2026 · NCT03326921MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
Namoota walitti qabaa jiraSadarkaa 2
Hanga umuriin 60 · Saalaa hunda · Haaromfame 06-Elb-2026 · NCT05735717Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.